The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics

Autor: Neil Gittoes, Lars Rejnmark, Steven W. Ing, Maria Luisa Brandi, Sigridur Björnsdottir, Stefanie Hahner, Lorenz C. Hofbauer, Pascal Houillier, Aliya A. Khan, Michael A. Levine, Michael Mannstadt, Dolores M. Shoback, Tamara J. Vokes, Pinggao Zhang, Claudio Marelli, John Germak, Bart L. Clarke

Publikováno v: BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-12 (2021)

Abstract Background The PARADIGHM registry of adult and pediatric patients with chronic hypoparathyroidism evaluates the long-term safety and effectiveness of treatment with recombinant human parathyroid hormone, rhPTH(1-84), and describes the clinic

Externí odkaz: https://doaj.org/article/12c9c84405614bd69518853f175c18a9

The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics

Autor: Bart L. Clarke, Claudio Marelli, Maria Luisa Brandi, Michael A. Levine, Sigridur Bjornsdottir, John Germak, Lars Rejnmark, Steven W. Ing, Michael Mannstadt, Dolores M. Shoback, Stefanie Hahner, Lorenz C. Hofbauer, Pinggao Zhang, Neil Gittoes, Tamara Vokes, Aliya Khan, Pascal Houillier

Publikováno v: BMC Endocrine Disorders
BMC Endocrine Disorders, BioMed Central, 2019, 21 (1), ⟨10.1186/s12902-021-00888-2⟩
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-12 (2021)
Gittoes, N, Rejnmark, L, Ing, S W, Brandi, M L, Björnsdottir, S, Hahner, S, Hofbauer, L C, Houillier, P, Khan, A A, Levine, M A, Mannstadt, M, Shoback, D M, Vokes, T J, Zhang, P, Marelli, C, Germak, J & Clarke, B L 2021, ' The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism : study protocol and interim baseline patient characteristics ', BMC Endocrine Disorders, vol. 21, no. 1, 232 . https://doi.org/10.1186/s12902-021-00888-2

Background The PARADIGHM registry of adult and pediatric patients with chronic hypoparathyroidism evaluates the long-term safety and effectiveness of treatment with recombinant human parathyroid hormone, rhPTH(1-84), and describes the clinical diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::837401b22db82109ff6d833bf6b62c7f
https://hal.sorbonne-universite.fr/hal-03456894